​

Gyre Therapeutics Ownership | Who Owns Gyre Therapeutics?

OverviewRevenueFinancialsChart

Gyre Therapeutics Ownership Summary

Gyre Therapeutics is owned by 3.02% institutional investors, 85.75% insiders, and 11.24% retail investors. Federation des caisses desjardins du quebec is the largest institutional shareholder, holding 0% of GYRE shares.

GYRE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockGyre Therapeutics3.02%85.75%11.24%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Federation des caisses desjardins du quebec---
Belvedere trading---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Federation des caisses desjardins du quebec---
Belvedere trading---

Top Buyers

HolderShares% AssetsChange
Federation des caisses desjardins du quebec---75.00
Belvedere trading---2.46K

Top Sellers

HolderShares% AssetsChange
Belvedere trading---2.46K
Federation des caisses desjardins du quebec---75.00

Sold Out

HolderChange
Federation des caisses desjardins du quebec-75.00
Belvedere trading-2.46K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20254415.79%2,609,38057.10%380.28%2315.00%1455.56%
Dec 31, 20243911.43%1,787,60711.02%259.05%21-4.55%950.00%
Sep 30, 20243516.67%1,610,23828.03%186.89%22-12.00%620.00%
Jun 30, 20243050.00%1,257,75153.98%1152.85%2566.67%525.00%
Mar 31, 20242025.00%816,84334.62%-156.32%15-4-

Recent Insider Transactions

DateNameRoleActivityValue
May 28, 2025Ma Songjiang PresidentSell$5.62K
May 27, 2025Ma Songjiang PresidentSell$20.56K
May 23, 2025Ma Songjiang PresidentSell$1.86K
May 22, 2025Ma Songjiang PresidentSell$21.94K
May 20, 2025Ma Songjiang PresidentSell$22.50K

Insider Transactions Trends

DateBuySell
2025 Q2-12
2025 Q1-59
2024 Q4-14
2024 Q3--
2024 Q2-5

GYRE Ownership FAQ

Who Owns Gyre Therapeutics?

Gyre Therapeutics shareholders are primarily institutional investors at 3.02%, followed by 85.75% insiders and 11.23% retail investors. The average institutional ownership in Gyre Therapeutics's industry, Biotech Stocks , is 63.96%, which Gyre Therapeutics falls below.

Does Blackrock own Gyre Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Gyre Therapeutics.

Who is Gyre Therapeutics’s biggest shareholder by percentage of total assets invested?

Federation des caisses desjardins du quebec is Gyre Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Gyre Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools